Update on cultured autologous tumor cells and dendritic cells as patient-specific vaccines in recurrent or metastatic melanoma or renal cell cancer

被引：0
|
作者：
Dillman, R [1 ]
Selvan, S [1 ]
Schiltz, P [1 ]
Allen, K [1 ]
DePriest, C [1 ]
Beatty, A [1 ]
de Leon, C [1 ]
Beutel, L [1 ]
Peterson, C [1 ]
Ellis, R [1 ]
机构：
[1] Hoag Mem Hosp Presbyterian, Hoag Canc Ctr, Newport Beach, CA USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2003年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [1] Dendritic cells loaded with proliferating autologous tumor cells as patient-specific vaccines in recurrent or metastatic melanoma and renal cell cancer
    Dillman, Robert O.
    Selvan, Senthamil R.
    Schiltz, Patric M.
    Allen, Kanoelani
    Peterson, Cheryl
    De Leon, Cristina
    Depriest, Carol
    Beatty, Andrea
    Beutel, Linda D.
    CANCER RESEARCH, 2006, 66 (08)
  • [2] Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
    Dillman, Robert O.
    Cornforth, Andrew N.
    McClay, Edward F.
    Depriest, Carol
    MELANOMA MANAGEMENT, 2019, 6 (02)
  • [3] Features Associated with Survival in Metastatic Melanoma Patients Treated with Patient-Specific Vaccines Consisting of Proliferating Autologous Tumor Cells and Autologous Dendritic Cells
    Dillman, Robert O.
    Fogel, Gary B.
    Cornforth, Andrew N.
    DePriest, Carol
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 876 - 876
  • [4] Patient-specific vaccines derived from proliferating autologous tumor cell lines and dendritic cells: Results of a phase II trial in metastatic melanoma
    Dillman, R. O.
    Selvan, S. R.
    Schiltz, P. M.
    DePriest, C.
    Peterson, C.
    DeLeon, C.
    McClay, E. F.
    Barth, N. M.
    Sheehy, P. F.
    Allen, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Patient-specific dendritic-cell vaccines for metastatic melanoma
    Dillman, Robert O.
    Selvan, Senthamil R.
    Schiltz, Patric M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11): : 1179 - 1181
  • [6] Survival in successive phase II trials of patient-specific vaccines from autologous tumor cell lines, with or without dendritic cells, in patients with metastatic melanoma
    Dillman, Robert O.
    Selvan, Senthamil R.
    Schiltz, Patric M.
    Allen, Kanoe
    DePriest, Carol
    Peterson, Cheryl
    DeLeon, Cristina
    McClay, Edward F.
    Barth, Neil M.
    Sheehy, Patrick F.
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 647 - 647
  • [7] Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
    Dillman, Robert O.
    Nistor, Gabriel I.
    Keirstead, Hans S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [8] Pure autologous tumor cells (TC) and dendritic cells (DC) with GM-CSF: Patient-specific vaccine for metastatic melanoma.
    Dillman, RO
    Selvan, SR
    Schiltz, PM
    Allen, K
    Depriest, C
    McClay, EF
    Barth, NM
    Sheehy, PF
    De Leon, C
    Peterson, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 721S - 721S
  • [9] Randomized trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma
    Dillman, Robert
    McClay, Edward
    Amatruda, Thomas
    Cornforth, Andrew
    Depriest, Carol
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [10] Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report
    Dillman, Robert O.
    Selvan, Senthamil R.
    Schiltz, Patric M.
    McClay, Edward F.
    Barth, Neil M.
    DePriest, Carol
    de Leon, Cristina
    Mayorga, Cheryl
    Cornforth, Andrew N.
    Allen, Kanoe
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (03) : 311 - 319
12345